BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16266991)

  • 1. Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course.
    Irving JA; Minto L; Bailey S; Hall AG
    Cancer Res; 2005 Nov; 65(21):9712-8. PubMed ID: 16266991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo.
    Hillmann AG; Ramdas J; Multanen K; Norman MR; Harmon JM
    Cancer Res; 2000 Apr; 60(7):2056-62. PubMed ID: 10766198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.
    Irving JA; Bloodworth L; Bown NP; Case MC; Hogarth LA; Hall AG
    Cancer Res; 2005 Apr; 65(8):3053-8. PubMed ID: 15833833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.
    Strasser-Wozak EM; Hattmannstorfer R; Hála M; Hartmann BL; Fiegl M; Geley S; Kofler R
    Cancer Res; 1995 Jan; 55(2):348-53. PubMed ID: 7812967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allelic loss of 6q16.3 microsatellite DNA in childhood acute lymphoblastic leukemia and bioinformatics analysis].
    Yang MH; Cao LZ; Yu Y; Zhang ZX; Wang Y; Kang R; Chen Y; Tan ZH; Wu XS
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):289-93. PubMed ID: 16875573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
    Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
    Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of the glucocorticoid receptor level in the bone marrow blast cells of children with leukemias].
    Gershteĭn ES; Smirnova KD; Moiseenko EI; Bassalyk LS
    Vopr Onkol; 1987; 33(1):20-4. PubMed ID: 3811305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.
    Namazi S; Zareifar S; Monabati A; Ansari S; Karimzadeh I
    Clin Ther; 2011 Mar; 33(3):280-90. PubMed ID: 21497906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
    McEvoy CR; Morley AA; Firgaira FA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
    Lambrou GI; Vlahopoulos S; Papathanasiou C; Papanikolaou M; Karpusas M; Zoumakis E; Tzortzatou-Stathopoulou F
    Leuk Res; 2009 Dec; 33(12):1684-95. PubMed ID: 19450877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early resistance to therapy during induction in childhood acute lymphoblastic leukemia.
    Brisco MJ; Sykes PJ; Dolman G; Hughes E; Neoh SH; Peng L; Snell LE; Toogood IR; Rice MS; Morley AA
    Cancer Res; 2000 Sep; 60(18):5092-6. PubMed ID: 11016634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.